Results 71 to 80 of about 9,019 (165)

Empirical noise mapping guides optimal region‐of‐interest selection for accurate noise estimation in prostate DWI

Journal of Applied Clinical Medical Physics, Volume 27, Issue 9, September 2026.
Abstract Background Signal‐to‐noise ratio (SNR) measurements are important for quality assurance, especially when quantitative MRI markers or new hardware are being developed or evaluated. Regions of low signal or assumed uniform signal are used for SNR estimation in a variety of MR image types, but this is unreliable due to spatial heterogeneity of ...
Milica Medved, Aritrick Chatterjee, Ambereen Yousuf, Batuhan Gundogdu, Aytekin Oto, Gregory S. Karczmar   +5 more
wiley   +1 more source

Image of transrectal micro-US-targeted biopsy with no mpMRI fusion.

, 2023
Image of transrectal micro-US-targeted biopsy with no mpMRI fusion.
Max Peters (11054192), Peter S. N. van Rossum (5241293), Massimo Valerio (6527399), Stefano La Rosa (251351), Beat Roth (382495), Jean-Yves Meuwly (7143911), Arnas Rakauskas (14445458), Paul Martel (14445461)   +7 more
core   +1 more source

Optimal Selection of the Effective Echo Time (TEeff ) for T2‐Weighted Fast‐Spin‐Echo MRI of the Prostate at 3.0 T: Effect on Lesion Conspicuity

Journal of Magnetic Resonance Imaging, Volume 64, Issue 3, Page 616-628, September 2026.
ABSTRACT Background Clinical T 2‐weighted (T2W) MRI of prostate cancer (PCa) usually implements a 2D fast‐spin‐echo (FSE) sequence, but understanding the echo‐time‐dependent contrast behavior is not straightforward due to the complicated FSE signal evolution.
Dahan Kim, Ronard Pabi, Eric A. Borisch, Adam T. Froemming, Roger C. Grimm, Sara Hassanzadeh, Akira Kawashima, Ayumu Kido, Naoki Takahashi, John V. Thomas, Stephen J. Riederer   +10 more
wiley   +1 more source

Impact of pre-biopsy mpMRI on prostate cancer detection in Switzerland [PDF]

Hintergrund Prostatakrebs (PCa) ist die häufigste Krebsart von Schweizer Männern und wird mittels einer Biopsie der Prostata diagnostiziert. PCa niedriger Aggressivität (LR, low risk) kann überwacht werden, während bei Krebs mittlerer (IR, intermediate ...
Scherer, Thomas Paul
core   +2 more sources

European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction‐associated steatotic liver disease

Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 3, Page 555-576, September 2026.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common reason for elevated liver enzymes in children in Europe, affecting more than 5% of all children. Since the last iteration of this position paper, there have been substantial advances in our understanding of the disease.
Jake P. Mann, Sander Lefere, Maarten Buytaert, Anna Alisi, Cigdem Arikan, Jernej Brecelj, Rachel M. Brown, Irene Degrassi, Giulia Fiore, Emer Fitzpatrick, Sven Francque, Christian A. Hudert, Wojciech Janczyk, Lauren Johansen, Bart G. Koot, Anastasia Konidari, Eberhard Lurz, Claudia Mandato, Maria Mercadal‐Hally, Hadar Moran‐Lev, Antonella Mosca, Giusy Ranucci, Maria Rogalidou, Penelope C. Rose, Piotr Socha, Pietro Vajro, Elvira Verduci, Anita C. E. Vreugdenhil, Natalia Zavhorodnia, Aglaia Zellos, Ruth De Bruyne   +30 more
wiley   +1 more source

Prostate Cancer Development, Progression, and Therapy

MedComm – Oncology, Volume 5, Issue 3, September 2026.
This review provides an integrated overview of prostate cancer development, progression, and therapy, spanning historical milestones, molecular mechanisms, advanced research models, and emerging therapeutic strategies. It highlights recent advances in precision diagnosis, lineage plasticity, therapy resistance, and next‐generation treatments for ...
Xin Jin, Zicheng Xiao, Zexian Ding, Wei Li, Ruijiang Zeng, Yujun Shuai, Weimin Ci, Dan Xia, Xu Zhang, Haojie Huang   +9 more
wiley   +1 more source

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer

BJUI Compass
Objectives To study the impact of the new MRI pathway and conventional transrectal ultrasound‐guided systematic biopsies (TRUSGB) on anxiety and HRQoL in men with suspected PCa.
Esther H. J. Hamoen, Bas Israël, Marloes van derLeest, Erik B. Cornel, O. Sjoerd Klaver, Rianne J. Hendriks, Jeroen Veltman, Inge M. vanOort, Gerjon Hannink, J. Alfred Witjes, Jelle O. Barentsz, Maroeska M. Rovers   +11 more
doaj   +1 more source

Probabilistic quality assurance of biopsy DVH thresholds in HDR prostate brachytherapy under localization uncertainty

Journal of Applied Clinical Medical Physics, Volume 27, Issue 8, August 2026.
Abstract Background MR‐US guided biopsies support biologic correlation in HDR prostate brachytherapy, but steep dose gradients and millimeter‐scale localization uncertainty limit the validity of nominal biopsy doses. Purpose To assess how localization uncertainty affects the robustness of biopsy DVH dose thresholds in HDR prostate brachytherapy and to ...
Matthew Muscat, Juanita Crook, Andrew Jirasek, Jeffrey Andrews, Nathan Becker   +4 more
wiley   +1 more source

PSMA PET/CT and mpMRI discrepancies in prostate cancer detection with whole-mount histopathology gold standard. [PDF]

284 Background: Multiparametric MRI (mpMRI) and PSMA-PET are complementary imaging modalities used in the pre-surgical evaluation of patients with prostate cancer (PCa).
Zong, Yang, Ban, David, Raman, Steven, Sisk, Anthony E, Grogan, Tristan, Doddipalli, Sahith, Reiter, Robert Evan, Ahuja, Preeti, Sonni, Ida, Calais, Jeremie, Kim, Hye Ok, Barroso, Nashla, Czernin, Johannes, Deol, Madhvi, Soin, Priti, Hsu, William, Weiner, Adam B   +16 more
core   +1 more source

Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients

, 2020
Purpose!#!Accurate delineation of intraprostatic gross tumor volume (GTV) is mandatory for successful fusion biopsy guidance and focal therapy planning of prostate cancer (PCa).
Fassbender, Thomas F., Jaegle, Chiara, Nicolay, Nils H., Zamboglou, Constantinos, Benndorf, Matthias, Sprave, Tanja, Bock, Michael, Ruf, Juri, Spohn, Simon, Gkika, Eleni, Gratzke, Christian, Benndorf, Matthias ; https://orcid.org/, Grosu, Anca L.   +12 more
core   +1 more source